Laura Iezzi
Giulianova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
TNBC, stage IV: a patient's journey, from standard options to the new era of ADC.
Journal: Recenti progressi in medicina
Published: November 17, 2024
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Journal: Cancer immunology, immunotherapy : CII
Published: April 01, 2024
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
Journal: Therapeutic advances in medical oncology
Published: May 18, 2021
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting.
Journal: Cells
Published: May 07, 2021
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.
Journal: Journal of cancer research and clinical oncology
Published: April 28, 2019
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Journal: International journal of cancer
Published: April 15, 2019
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression.
Journal: Case reports in oncological medicine
Published: March 06, 2019
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
Journal: Breast (Edinburgh, Scotland)
Published: November 22, 2018
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials.
Journal: Journal of clinical medicine
Published: November 15, 2018
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Journal: Cancer biology & therapy
Published: November 08, 2018
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting.
Journal: Therapeutic advances in medical oncology
Published: October 16, 2018
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
Journal: Journal of cellular physiology
Published: October 10, 2018
Last Updated: 09/26/2026